Shinpoong Pharmaceutical Co Ltd (019175) — Capital Reinvestment Ratio
Latest as of March 2026:
0.09x
Shinpoong Pharmaceutical Co Ltd (019175) has a Capital Reinvestment Ratio of 0.09x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩6.36 Billion) in capital expenditures (₩557.84 Million). See 019175 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.09x
Capex / Operating Cash Flow
Operating Cash Flow
₩6.36 Billion
KRW
Capital Expenditures
₩557.84 Million
KRW
Data as of
Mar 2026
Most recent filing
Shinpoong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks Shinpoong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Shinpoong Pharmaceutical Co Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for Shinpoong Pharmaceutical Co Ltd from 2015 to 2025. For live market cap and broader valuation context, see market cap of Shinpoong Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | ₩17.25 Billion | ₩3.99 Billion | ▲ +74.8% |
| 2020 | 0.13x | ₩20.06 Billion | ₩2.65 Billion | ▼ -78.8% |
| 2019 | 0.62x | ₩19.35 Billion | ₩12.07 Billion | ▲ +1015.9% |
| 2018 | 0.06x | ₩32.05 Billion | ₩1.79 Billion | ▼ -81.6% |
| 2017 | 0.30x | ₩10.15 Billion | ₩3.08 Billion | ▲ +283.0% |
| 2016 | 0.08x | ₩18.96 Billion | ₩1.50 Billion | ▼ -58.7% |
| 2015 | 0.19x | ₩9.89 Billion | ₩1.90 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow